CHEMBL1423

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:contraindication heart block
cardiogenic shock
sinus bradycardia
overt cardiac failure
gptkbp:drugClass beta blocker
beta-adrenergic antagonist
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion gptkb:kidney
gptkbp:hasHBA 4
gptkbp:hasHBD 3
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasRotatableBonds 7
gptkbp:hasSMILES CC(C)NCC(COC1=CC=CC=C1C(=O)N)O
gptkbp:hasTPSA 81.18
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL1423
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
gptkbp:isApprovedDrug true
gptkbp:legalStatus off-patent
Rx-only (US)
POM (UK)
gptkbp:listedOn gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:mechanismOfAction selective beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:metabolism liver
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID 2162
DB00335
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect dizziness
fatigue
bradycardia
cold extremities
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
beta-2 adrenergic receptor (low affinity)
gptkbp:bfsParent gptkb:Naltrexone
gptkb:adefovir
gptkb:dimethyl_sulfoxide
gptkbp:bfsLayer 6